CSRM617
- Product Code: 124716
CAS:
787504-88-5
| Molecular Weight: | 255.23 g./mol | Molecular Formula: | C₁₀H₁₃N₃O₅ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
CSRM617 is primarily utilized in the field of oncology research as a potent and selective inhibitor of specific kinase enzymes involved in cancer cell proliferation and survival. It is extensively studied for its potential to disrupt signaling pathways that drive tumor growth, making it a promising candidate for targeted cancer therapies. Researchers employ CSRM617 in preclinical studies to evaluate its efficacy in inhibiting tumor progression and to understand its mechanism of action at the molecular level. Additionally, it is used in combination studies with other anticancer agents to explore synergistic effects and enhance therapeutic outcomes. Its application is particularly relevant in the development of treatments for cancers that are resistant to conventional therapies, offering hope for improved patient outcomes.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Off-White To Pale Beige Solid |
| Purity (%) | 95.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | £131.18 |
+
-
|
| 0.005 | 10-20 days | £489.66 |
+
-
|
CSRM617
CSRM617 is primarily utilized in the field of oncology research as a potent and selective inhibitor of specific kinase enzymes involved in cancer cell proliferation and survival. It is extensively studied for its potential to disrupt signaling pathways that drive tumor growth, making it a promising candidate for targeted cancer therapies. Researchers employ CSRM617 in preclinical studies to evaluate its efficacy in inhibiting tumor progression and to understand its mechanism of action at the molecular level. Additionally, it is used in combination studies with other anticancer agents to explore synergistic effects and enhance therapeutic outcomes. Its application is particularly relevant in the development of treatments for cancers that are resistant to conventional therapies, offering hope for improved patient outcomes.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
£0.00
£0.00
Total :